RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Shares of Vertex Pharmaceuticals rose after Journavx, the company's oral non-opioid pain medication, received Food and Drug Administration approval. The Boston company's stock rose 4.3%, to $457.25, ...
Robert F. Kennedy Jr.'s second confirmation hearing highlights vaccine skepticism, bipartisan concerns, and his plans as ...
The final round of committee hearings for Kennedy’s bid to be HHS Secretary was contentious from the start.
RFK Jr.'s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT's live updates.
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
President Donald Trump, in signing dozens of executive orders on Monday, rescinded an effort by former President Joe Biden to lower drug costs by directing Medicare and Medicaid to test models that ...
The Biden administration, in its last full weekday in office, has announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the ...
Medicare’s next drug price negotiations will treat ... rather than treat each use approved by the Food and Drug Administration separately. “The statute and our guidance [are] very clear that when a ...
Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug ...